STDs 3: 340
tubal ligation 3: 347
urethritis 3: 222
varicocele 3: 353
vasectomy 3:354–355
inflammation 2:277
antihistamine medications
2: 247
atelectasis 2: 190
atherosclerotic plaque 2: 22
berylliosis 2: 192
bronchitis 2: 196
bronchus 2: 198
bursa 1: 312
bursitis 1:312
cellulitis 1:143–144
chondritis 1:318
chondroitin 4: 64
COPD 2: 199
c-reactive protein 2:45–46
cytokines 2: 257
endocarditis 2:53–54
epicondylitis 1:320–321
erythema nodosum 1: 156
garlic 4: 69
granuloma 2: 265
histamine 2: 267
immune response 2: 273
immune system 2:236, 238
immunotherapy 2: 276
infection 2: 338
infectious arthritis 1:328
interferons 2: 278
interleukins 2: 278
leukotrienes 2:279
lung abscess 2: 208
macrophage 2: 282
mast cell 2: 283
meningitis 2:343–344
miliaria 1: 176
NSAIDs 2: 286
otitis 1:40
pain 1: 382
pericarditis 2:95–96
plantar fasciitis 1:349–350
pleura 2: 218
polymyositis 1:350
prostaglandins 2: 290
rheumatoid arthritis 2:291–292
RICE 1: 353
rotator cuff impingement
syndrome 1: 353
sarcoidosis 2:293–294
shin splints 4: 231
soft tissue injuries 4: 367
synovitis 1:357
tendonitis 1:359–360
TGFs 2: 297
toxic shock syndrome 2: 357
inflammation response 1:363;
2:136, 163
inflammatory bowel disease (IBD)
3:61–64, 62 t, 63 t
ankylosing spondylitis 1: 303
antidiarrheal medications 3: 13
colitis 3: 25
colostomy 3: 31
5ASA medications 2: 260
ileoanal reservoir 3: 60
nephrolithiasis 3: 209
primary sclerosing cholangitis
3: 84
TNFs 2: 297
influenza 2:338–340
echinacea 4: 67
infectious diseases 2: 303
lung transplantation 2: 213
NALT 2: 288
pericarditis 2: 95
pneumonia 2: 220
preventive medicine 4: 2
sneeze/cough etiquette 2: 354
vaccine 2: 298
influenza A 2:221, 338; 4: 35
influenza B 2:221, 338; 4: 35
influenza prevention 4:34–36
ingested toxins 4: 42 , 383–384
ingrown hair 1:166–167, 188
ingrown nail 1:167
inhalation burns 4: 363 , 365, 385
inhaled toxins 4:42, 365, 381,
384–385, 384 t, 386
inheritance pattern 1:222, 225,
256, 269, 335
inheritance patterns 4:132–133,
133 t
inhibin 3: 100 , 148, 151
injected toxins 4:385
injecting drugs, risks of 4:31, 312,
340–341, 385
innate immunity 2: 274 , 277–278
inner ear 1:3–4, 11–12, 16–17, 20,
31, 33–35, 60–61, 350
innovator drug 4:146, 153, 158,
159, 163
inotropics 2:81, 85t
insanity 3:376
insulin 2:8, 72–73, 90, 97, 249;
3:148
cloning 4: 119
diabetes 3: 119
endocrine system 3: 100gastrointestinal system 3: 3
genetics and molecular medicine
4: 112
glucagon 3: 128
glucose 3: 128
hypoglycemia 3: 142
insulin resistance 3: 149
islet cell transplantation 3: 149
islets of Langerhans 3: 149
metabolism 4: 225
pancreas 3: 79
recombinant DNA 4: 139
insulin resistance 2:25, 49;
3:148–149
diabetes 3: 120
diabetes prevention 4: 19
gestational diabetes 3: 288
ginseng 4: 72
hypoglycemia 3: 142
menopause 3: 302
obesity and health 4: 301
PCOS 3: 320
pharmacodynamics 4: 168
polyglandular deficiency
syndrome 3: 156
insulin therapy 3:120, 121, 149
integrative medicine 4:78
integumentary system 1:125–211,
126
breakthrough research and
treatment advances 1: 130
dermis 1:127–128, 128t
embryonic development 1: 125
epidermis 1:127, 127t
fingernails and toenails 1: 129
functions of 1:125–129
hair 1:128–129
health and disorders 1:129–130,
130 t
overview 1:125–130
structures of 1: 125
subcutaneous layer 1: 128
traditions in medical history
1: 129
interaction. Seedrug interaction
interferons 2: 276 , 278,368, 372
interleukins 2:278; 4: 95
cancer treatment options and
decisions 2: 372
fever 2: 326
immunotherapy 2: 276
psychoneuroimmunology 2: 290
TGFs 2: 297
TNFs 2: 297
intermittent claudication 2:69, 78 ,
79 , 96Index 481